Form 8-K ARGOS THERAPEUTICS INC For: Aug 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Argos Therapeutics (ARGS) Misses Q2 EPS by 5c
August 10, 2016 4:24 PM EDTArgos Therapeutics (NASDAQ: ARGS) reported Q2 EPS of ($0.48), $0.05 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $488.64 thousand versus the consensus estimate of $200 thousand.
For earnings history and earnings-related data on Argos Therapeutics (ARGS) click here.
... More